News | May 23, 2026
Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
Transition to a fermentation-based globally integrated CDMO platform
Transition to a fermentation-based globally integrated CDMO platform
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Move strengthens footprint in Western India and expands multi-specialty care network
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The initial consideration for the transaction is US$ 12 million
Subscribe To Our Newsletter & Stay Updated
